PFE - Viking Therapeutics gains on early data for oral weight loss therapy
2024-03-26 07:37:54 ET
More on Viking Therapeutics
- Shaping The Future Of Obesity Treatment: GLP-1 Agonists At The Forefront
- Viking Therapeutics: Here To Stay In Obesity, Or A Flash In The Pan?
- Viking Therapeutics: VK2735 Data Supports A Buyout
- Jefferies starts Viking Therapeutics at buy, cites "scarcity value"
- Viking Therapeutics stock dips after pricing $550M stock offering